Journal of Biomedicine and Biotechnology
Volume 2009 (2009), Article ID 654346, 13 pages
doi:10.1155/2009/654346
Review Article

MicroRNA Implications across Neurodevelopment and Neuropathology

Sabata Martino,1 Ilaria di Girolamo,1 Antonio Orlacchio,2,3 Alessandro Datti,1 and Aldo Orlacchio1

1Dipartimento di Medicina Sperimentale e Scienze Biochimiche, Sezione di Biochimica e Biologia Molecolare, Università di Perugia, Via del Giochetto, 06126 Perugia, Italy
2Laboratorio di Neurogenetica, CERC-IRCCS Santa Lucia, Via del Fosso di Fiorano 64, 00143 Rome, Italy
3Dipartimento di Neuroscienze, Università di Roma “Tor Vergata”, Viale Oxford 81, 00133 Rome, Italy

Received 2 February 2009; Revised 11 May 2009; Accepted 20 July 2009

Academic Editor: Ravi Sachidanandam

Copyright © 2009 Sabata Martino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. P. Bartel, “microRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Meister, “miRNAs get an early start on translational silencing,” Cell, vol. 131, no. 1, pp. 25–28, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  3. M. Kiriakidou, G. S. Tan, S. Lamprinaki, M. De Planell-Saguer, P. T. Nelson, and Z. Mourelatos, “An mRNA m7G cap binding-like motif within human Ago2 represses translation,” Cell, vol. 129, no. 6, pp. 1141–1151, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  4. G. Mathonnet, M. R. Fabian, Y. V. Svitkin, et al., “microRNA inhibition of translation initiation in vitro by targeting the cap-binding complex eIF4F,” Science, vol. 317, no. 5845, pp. 1764–1767, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  5. R. Thermann and M. W. Hentze, “Drosophila miR2 induces pseudo-polysomes and inhibits translation initiation,” Nature, vol. 447, no. 7146, pp. 875–878, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  6. M. Wakiyama, K. Takimoto, O. Ohara, and S. Yokoyama, “Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system,” Genes and Development, vol. 21, no. 15, pp. 1857–1862, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  7. X. C. Ding, J. Weiler, and H. Grosshans, “Regulating the regulators: mechanisms controlling the maturation of microRNAs,” Trends in Biotechnology, vol. 27, no. 1, pp. 27–36, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  8. D. J. Guarnieri and R. J. DiLeone, “microRNAs: a new class of gene regulators,” Annals of Medicine, vol. 40, no. 3, pp. 197–208, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  9. A. Köhler and E. Hurt, “Exporting RNA from the nucleus to the cytoplasm,” Nature Reviews Molecular Cell Biology, vol. 8, no. 10, pp. 761–773, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  10. A. Orlacchio, G. Bernardi, A. Orlacchio, and S. Martino, “Patented therapeutic RNAi strategies for neurodegenerative diseases of the CNS,” Expert Opinion on Therapeutic Patents, vol. 18, no. 10, pp. 1161–1174, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. S. S. Hébert and B. De Strooper, “Molecular biology: miRNAs in neurodegeneration,” Science, vol. 317, no. 5842, pp. 1179–1180, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  12. S. S. Hébert and B. De Strooper, “Alterations of the microRNA network cause neurodegenerative disease,” Trends in Neurosciences, vol. 32, no. 4, pp. 199–206, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  13. S. K. Singh, “miRNAs: from neurogeneration to neurodegeneration,” Pharmacogenomics, vol. 8, no. 8, pp. 971–978, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  14. R. W. Carthew and E. J. Sontheimer, “Origins and mechanisms of miRNAs and siRNAs,” Cell, vol. 136, no. 4, pp. 642–655, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  15. V. N. Kim, J. Han, and M. C. Siomi, “Biogenesis of small RNAs in animals,” Nature Reviews Molecular Cell Biology, vol. 10, no. 2, pp. 126–139, 2009. View at Publisher · View at Google Scholar · View at PubMed
  16. M. J. Moore and N. J. Proudfoot, “Pre-mRNA processing reaches back to transcription and ahead to translation,” Cell, vol. 136, no. 4, pp. 688–700, 2009. View at Publisher · View at Google Scholar · View at PubMed
  17. A. Rodriguez, S. Griffiths-Jones, J. L. Ashurst, and A. Bradley, “Identification of mammalian microRNA host genes and transcription units,” Genome Research, vol. 14, no. 10A, pp. 1902–1910, 2004. View at Publisher · View at Google Scholar · View at PubMed
  18. Y.-K. Kim and V. N. Kim, “Processing of intronic microRNAs,” EMBO Journal, vol. 26, no. 3, pp. 775–783, 2007. View at Publisher · View at Google Scholar · View at PubMed
  19. X. Cai, C. H. Hagedorn, and B. R. Cullen, “Human microRNAs are processed from capped, polyadenylated transcripts that can also function as mRNAs,” RNA, vol. 10, no. 12, pp. 1957–1966, 2004. View at Publisher · View at Google Scholar · View at PubMed
  20. Y. Lee, M. Kim, J. Han, et al., “microRNA genes are transcribed by RNA polymerase II,” EMBO Journal, vol. 23, no. 20, pp. 4051–4060, 2004. View at Publisher · View at Google Scholar · View at PubMed
  21. U. Ohler, S. Yekta, L. P. Lim, D. P. Bartel, and C. B. Burge, “Patterns of flanking sequence conservation and a characteristic upstream motif for microRNA gene identification,” RNA, vol. 10, no. 9, pp. 1309–1322, 2004. View at Publisher · View at Google Scholar · View at PubMed
  22. X. Liu, K. Fortin, and Z. Mourelatos, “microRNAs: biogenesis and molecular functions,” Brain Pathology, vol. 18, no. 1, pp. 113–121, 2008. View at Publisher · View at Google Scholar · View at PubMed
  23. Y. Lee, K. Jeon, J.-T. Lee, S. Kim, and V. N. Kim, “microRNA maturation: stepwise processing and subcellular localization,” EMBO Journal, vol. 21, no. 17, pp. 4663–4670, 2002. View at Publisher · View at Google Scholar
  24. A. M. Denli, B. B. J. Tops, R. H. A. Plasterk, R. F. Ketting, and G. J. Hannon, “Processing of primary microRNAs by the microprocessor complex,” Nature, vol. 432, no. 7014, pp. 231–235, 2004. View at Publisher · View at Google Scholar · View at PubMed
  25. R. I. Gregory, K.-P. Yan, G. Amuthan, et al., “The microprocessor complex mediates the genesis of microRNAs,” Nature, vol. 432, no. 7014, pp. 235–240, 2004. View at Publisher · View at Google Scholar · View at PubMed
  26. J. Han, Y. Lee, K.-H. Yeom, Y.-K. Kim, H. Jin, and V. N. Kim, “The Drosha-DGCR8 complex in primary microRNA processing,” Genes and Development, vol. 18, no. 24, pp. 3016–3027, 2004. View at Publisher · View at Google Scholar · View at PubMed
  27. M. Landthaler, A. Yalcin, and T. Tuschl, “The human DiGeorge syndrome critical region gene 8 and its D. melanogaster homolog are required for miRNA biogenesis,” Current Biology, vol. 14, no. 23, pp. 2162–2167, 2004. View at Publisher · View at Google Scholar · View at PubMed
  28. E. Berezikov, W.-J. Chung, J. Willis, E. Cuppen, and E. C. Lai, “Mammalian mirtron genes,” Molecular Cell, vol. 28, no. 2, pp. 328–336, 2007. View at Publisher · View at Google Scholar · View at PubMed
  29. K. Okamura, J. W. Hagen, H. Duan, D. M. Tyler, and E. C. Lai, “The mirtron pathway generates microRNA-class regulatory RNAs in Drosophila,” Cell, vol. 130, no. 1, pp. 89–100, 2007. View at Publisher · View at Google Scholar · View at PubMed
  30. J. G. Ruby, C. H. Jan, and D. P. Bartel, “Intronic microRNA precursors that bypass Drosha processing,” Nature, vol. 448, no. 7149, pp. 83–86, 2007. View at Publisher · View at Google Scholar · View at PubMed
  31. M. T. Bohnsack, K. Czaplinski, and D. Gorlich, “Exportin 5 is a RanGTP-dependent dsRNA-binding protein that mediates nuclear export of pre-miRNAs,” RNA, vol. 10, no. 2, pp. 185–191, 2004. View at Publisher · View at Google Scholar
  32. E. Lund, S. Guttinger, A. Calado, J. E. Dahlberg, and U. Kutay, “Nuclear export of microRNA precursors,” Science, vol. 303, no. 5654, pp. 95–98, 2004. View at Publisher · View at Google Scholar · View at PubMed
  33. W. Filipowicz, S. N. Bhattacharyya, and N. Sonenberg, “Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?” Nature Reviews Genetics, vol. 9, no. 2, pp. 102–114, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  34. M. Ronshaugen, F. Biemar, J. Piel, M. Levine, and E. C. Lai, “The Drosophila microRNA iab-4 causes a dominant homeotic transformation of halteres to wings,” Genes and Development, vol. 19, no. 24, pp. 2947–2952, 2005. View at Publisher · View at Google Scholar · View at PubMed
  35. R. Garzon, F. Pichiorri, T. Palumbo, et al., “microRNA fingerprints during human megakaryocytopoiesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 13, pp. 5078–5083, 2006. View at Publisher · View at Google Scholar · View at PubMed
  36. F.-B. Gao, “Posttranscriptional control of neuronal development by microRNA networks,” Trends in Neurosciences, vol. 31, no. 1, pp. 20–26, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  37. R. J. Johnston Jr. and O. Hobert, “A microRNA controlling left/right neuronal asymmetry in Caenorhabditis elegans,” Nature, vol. 426, no. 6968, pp. 845–849, 2003. View at Publisher · View at Google Scholar · View at PubMed
  38. R. J. Johnston Jr., S. Chang, J. F. Etchberger, C. O. Ortiz, and O. Hobert, “microRNAs acting in a double-negative feedback loop to control a neuronal cell fate decision,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 35, pp. 12449–12454, 2005. View at Publisher · View at Google Scholar · View at PubMed
  39. S. Yekta, I.-H. Shih, and D. P. Bartel, “microRNA-directed cleavage of HOXB8 mRNA,” Science, vol. 304, no. 5670, pp. 594–596, 2004. View at Publisher · View at Google Scholar · View at PubMed
  40. J. Visvanathan, S. Lee, B. Lee, J. W. Lee, and S.-K. Lee, “The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development,” Genes and Development, vol. 21, no. 7, pp. 744–749, 2007. View at Publisher · View at Google Scholar · View at PubMed
  41. L.-C. Cheng, E. Pastrana, M. Tavazoie, and F. Doetsch, “MiR-124 regulates adult neurogenesis in the subventricular zone stem cell niche,” Nature Neuroscience, vol. 12, no. 4, pp. 399–408, 2009. View at Publisher · View at Google Scholar · View at PubMed
  42. N. Vo, M. E. Klein, O. Varlamova, et al., “A cAMP-response element binding protein-induced microRNA regulates neuronal morphogenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 45, pp. 16426–16431, 2005. View at Publisher · View at Google Scholar · View at PubMed
  43. H.-Y. M. Cheng, J. W. Papp, O. Varlamova, et al., “microRNA modulation of circadian-clock period and entrainment,” Neuron, vol. 54, no. 5, pp. 813–829, 2007. View at Publisher · View at Google Scholar · View at PubMed
  44. J. Kim, K. Inoue, J. Ishii, et al., “A microRNA feedback circuit in midbrain dopamine neurons,” Science, vol. 317, no. 5842, pp. 1220–1224, 2007. View at Publisher · View at Google Scholar · View at PubMed
  45. G. M. Schratt, F. Tuebing, E. A. Nigh, et al., “A brain-specific microRNA regulates dendritic spine development,” Nature, vol. 439, no. 7074, pp. 283–289, 2006. View at Publisher · View at Google Scholar · View at PubMed
  46. A. Kuzin, M. Kundu, T. Brody, and W. F. Odenwald, “The Drosophila nerfin-1 mRNA requires multiple microRNAs to regulate its spatial and temporal translation dynamics in the developing nervous system,” Developmental Biology, vol. 310, no. 1, pp. 35–43, 2007. View at Publisher · View at Google Scholar · View at PubMed
  47. X. Cao, G. Yeo, A. R. Muotri, T. Kuwabara, and F. H. Gage, “Noncoding RNAs in the mammalian central nervous system,” Annual Review of Neuroscience, vol. 29, pp. 77–103, 2006. View at Publisher · View at Google Scholar · View at PubMed
  48. B. L. Davidson and R. L. Boudreau, “RNA interference: a tool for querying nervous system function and an emerging therapy,” Neuron, vol. 53, no. 6, pp. 781–788, 2007. View at Publisher · View at Google Scholar · View at PubMed
  49. J. C. Pearson, D. Lemons, and W. McGinnis, “Modulating Hox gene functions during animal body patterning,” Nature Reviews Genetics, vol. 6, no. 12, pp. 893–904, 2005. View at Publisher · View at Google Scholar · View at PubMed
  50. A. J. Giraldez, R. M. Cinalli, M. E. Glasner, et al., “microRNAs regulate brain morphogenesis in zebrafish,” Science, vol. 308, no. 5723, pp. 833–838, 2005. View at Publisher · View at Google Scholar · View at PubMed
  51. U. Hengst, L. J. Cox, E. Z. Macosko, and S. R. Jaffrey, “Functional and selective RNA interference in developing axons and growth cones,” Journal of Neuroscience, vol. 26, no. 21, pp. 5727–5732, 2006. View at Publisher · View at Google Scholar · View at PubMed
  52. K. S. Kosik, “The neuronal microRNA system,” Nature Reviews Neuroscience, vol. 7, no. 12, pp. 911–920, 2006. View at Publisher · View at Google Scholar · View at PubMed
  53. L. Smirnova, A. Gräfe, A. Seiler, S. Schumacher, R. Nitsch, and F. G. Wulczyn, “Regulation of miRNA expression during neural cell specification,” European Journal of Neuroscience, vol. 21, no. 6, pp. 1469–1477, 2005. View at Publisher · View at Google Scholar · View at PubMed
  54. M. Castoldi, S. Schmidt, V. Benes, et al., “A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA),” RNA, vol. 12, no. 5, pp. 913–920, 2006. View at Publisher · View at Google Scholar · View at PubMed
  55. S. Griffiths-Jones, “miRBase: the microRNA sequence database,” Methods in Molecular Biology, vol. 342, pp. 129–138, 2006.
  56. T. Babak, W. Zhang, Q. Morris, B. J. Blencowe, and T. R. Hughes, “Probing microRNAs with microarrays: tissue specificity and functional inference,” RNA, vol. 10, no. 11, pp. 1813–1819, 2004. View at Publisher · View at Google Scholar · View at PubMed
  57. O. Barad, E. Meiri, A. Avniel, et al., “microRNA expression detected by oligonucleotide microarrays: system establishment and expression profiling in human tissues,” Genome Research, vol. 14, no. 12, pp. 2486–2494, 2004. View at Publisher · View at Google Scholar · View at PubMed
  58. E. A. Miska, E. Alvarez-Saavedra, M. Townsend, et al., “Microarray analysis of microRNA expression in the developing mammalian brain,” Genome Biology, vol. 5, no. 9, article R68, 2004.
  59. L. F. Sempere, S. Freemantle, I. Pitha-Rowe, E. Moss, E. Dmitrovsky, and V. Ambros, “Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation,” Genome Biology, vol. 5, no. 3, article R13, 2004.
  60. J. Shingara, K. Keiger, J. Shelton, et al., “An optimized isolation and labeling platform for accurate microRNA expression profiling,” RNA, vol. 11, no. 9, pp. 1461–1470, 2005. View at Publisher · View at Google Scholar · View at PubMed
  61. J. M. Thomson, J. Parker, C. M. Perou, and S. M. Hammond, “A custom microarray platform for analysis of microRNA gene expression,” Nature Methods, vol. 1, no. 1, pp. 47–53, 2004.
  62. V. G. Tusher, R. Tibshirani, and G. Chu, “Significance analysis of microarrays applied to the ionizing radiation response,” Proceedings of the National Academy of Sciences of the United States of America, vol. 98, no. 9, pp. 5116–5121, 2001. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  63. K. K.-H. Farh, A. Grimson, C. Jan, et al., “The widespread impact of mammalian microRNAs on mRNA repression and evolution,” Science, vol. 310, no. 5755, pp. 1817–1821, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  64. H. Hohjoh and T. Fukushima, “Expression profile analysis of microRNA (miRNA) in mouse central nervous system using a new miRNA detection system that examines hybridization signals at every step of washing,” Gene, vol. 391, no. 1-2, pp. 39–44, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  65. P. Landgraf, M. Rusu, R. Sheridan, et al., “A mammalian microRNA expression atlas based on small RNA library sequencing,” Cell, vol. 129, no. 7, pp. 1401–1414, 2007. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  66. W. P. Kloosterman and R. H. A. Plasterk, “The diverse functions of microRNAs in animal development and disease,” Developmental Cell, vol. 11, no. 4, pp. 441–450, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  67. Y. Zeng and B. R. Cullen, “Recognition and cleavage of primary microRNA transcripts,” Methods in Molecular Biology, vol. 342, pp. 49–56, 2006. View at Scopus
  68. E. Berezikov, F. Thuemmler, L. W. van Laake, et al., “Diversity of microRNAs in human and chimpanzee brain,” Nature Genetics, vol. 38, no. 12, pp. 1375–1377, 2006. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  69. S. Griffiths-Jones, “The microRNA registry,” Nucleic Acids Research, vol. 32, pp. D109–D111, 2004. View at Scopus
  70. D. B. Dogini, P. A. O. Ribeiro, C. Rocha, T. C. Pereira, and I. Lopes-Cendes, “microRNA expression profile in murine central nervous system development,” Journal of Molecular Neuroscience, vol. 35, no. 3, pp. 331–337, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  71. J.-Y. Yu, K.-H. Chung, M. Deo, R. C. Thompson, and D. L. Turner, “microRNA miR-124 regulates neurite outgrowth during neuronal differentiation,” Experimental Cell Research, vol. 314, no. 14, pp. 2618–2633, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  72. Q. Shen and S. Temple, “Fine control: microRNA regulation of adult neurogenesis,” Nature Neuroscience, vol. 12, no. 4, pp. 369–370, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  73. G. A. Wayman, M. Davare, H. Ando, et al., “An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 26, pp. 9093–9098, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  74. R. R. Buss and R. W. Oppenheim, “Role of programmed cell death in normal neuronal development and function,” Anatomical Science International, vol. 79, no. 4, pp. 191–197, 2004. View at Scopus
  75. K. C. Martin and K. S. Kosik, “Synaptic tagging—who's it?” Nature Reviews Neuroscience, vol. 3, no. 10, pp. 813–820, 2002. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  76. L. Smirnova, A. Gräfe, A. Seiler, S. Schumacher, R. Nitsch, and F. G. Wulczyn, “Regulation of miRNA expression during neural cell specification,” European Journal of Neuroscience, vol. 21, no. 6, pp. 1469–1477, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  77. R. L. Judson, J. E. Babiarz, M. Venere, and R. Blelloch, “Embryonic stem cell-specific microRNAs promote induced pluripotency,” Nature Biotechnology, vol. 27, no. 5, pp. 459–461, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  78. K. D. Wilson, S. Venkatasubrahmanyam, F. Jia, N. Sun, A. J. Butte, and J. C. Wu, “microRNA profiling of human-induced pluripotent stem cells,” Stem Cells and Development, vol. 18, no. 5, pp. 749–757, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  79. S. S. Hébert, K. Horré, L. Nicolaï, et al., “Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/β-secretase expression,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 17, pp. 6415–6420, 2008. View at Publisher · View at Google Scholar · View at PubMed
  80. W. J. Lukiw, “Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus,” NeuroReport, vol. 18, no. 3, pp. 297–300, 2007. View at Publisher · View at Google Scholar · View at PubMed
  81. V. Boissonneault, I. Plante, S. Rivest, and P. Provost, “microRNA-298 and microRNA-328 regulate expression of mouse β-amyloid precursor protein-converting enzyme 1,” Journal of Biological Chemistry, vol. 284, no. 4, pp. 1971–1981, 2009. View at Publisher · View at Google Scholar · View at PubMed
  82. W. J. Lukiw, Y. Zhao, and J. G. Cui, “An NF-κB-sensitive micro RNA-146a-mediated inflammatory circuit in alzheimer disease and in stressed human brain cells,” Journal of Biological Chemistry, vol. 283, no. 46, pp. 31315–31322, 2008. View at Publisher · View at Google Scholar · View at PubMed
  83. S.-L. Ang, “Transcriptional control of midbrain dopaminergic neuron development,” Development, vol. 133, no. 18, pp. 3499–3506, 2006. View at Publisher · View at Google Scholar · View at PubMed
  84. Y. Lee, R. C. Samaco, J. R. Gatchel, C. Thaller, H. T. Orr, and H. Y. Zoghbi, “miR-19, miR-101 and miR-130 co-regulate ATXN1 levels to potentially modulate SCA1 pathogenesis,” Nature Neuroscience, vol. 11, no. 10, pp. 1137–1139, 2008. View at Publisher · View at Google Scholar · View at PubMed
  85. A. N. Packer, Y. Xing, S. Q. Harper, L. Jones, and B. L. Davidson, “The bifunctional microRNA miR-9/miR-9∗ regulates REST and CoREST and is downregulated in Huntington's disease,” Journal of Neuroscience, vol. 28, no. 53, pp. 14341–14346, 2008. View at Publisher · View at Google Scholar · View at PubMed
  86. R. Johnson, C. Zuccato, N. D. Belyaev, D. J. Guest, E. Cattaneo, and N. J. Buckley, “A microRNA-based gene dysregulation pathway in Huntington's disease,” Neurobiology of Disease, vol. 29, no. 3, pp. 438–445, 2008. View at Publisher · View at Google Scholar · View at PubMed
  87. A. Clop, F. Marcq, H. Takeda, et al., “A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep,” Nature Genetics, vol. 38, no. 7, pp. 813–818, 2006. View at Publisher · View at Google Scholar · View at PubMed
  88. J. A. Chan, A. M. Krichevsky, and K. S. Kosik, “microRNA-21 is an antiapoptotic factor in human glioblastoma cells,” Cancer Research, vol. 65, no. 14, pp. 6029–6033, 2005. View at Publisher · View at Google Scholar · View at PubMed
  89. J. Silber, D. A. Lim, C. Petritsch, et al., “miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells,” BMC Medicine, vol. 6, article 14, 2008. View at Publisher · View at Google Scholar · View at PubMed
  90. J. Pierson, B. Hostager, R. Fan, and R. Vibhakar, “Regulation of cyclin dependent kinase 6 by microRNA 124 in medulloblastoma,” Journal of Neuro-Oncology, vol. 90, no. 1, pp. 1–7, 2008. View at Publisher · View at Google Scholar · View at PubMed
  91. J. S. Wei, Y. K. Song, S. Durinck, et al., “The MYCN oncogene is a direct target of miR-34a,” Oncogene, vol. 27, no. 39, pp. 5204–5213, 2008. View at Publisher · View at Google Scholar · View at PubMed
  92. Y. Chen and R. L. Stallings, “Differential patterns of microRNA expression in neuroblastoma are correlated with prognosis, differentiation, and apoptosis,” Cancer Research, vol. 67, no. 3, pp. 976–983, 2007. View at Publisher · View at Google Scholar · View at PubMed
  93. A. Bottoni, D. Piccin, F. Tagliati, A. Luchin, M. C. Zatelli, and E. C. D. Uberti, “miR-15a and miR-16-1 down-regulation in pituitary adenomas,” Journal of Cellular Physiology, vol. 204, no. 1, pp. 280–285, 2005. View at Publisher · View at Google Scholar · View at PubMed
  94. A. P. Heaney, “Pituitary tumour pathogenesis,” British Medical Bulletin, vol. 75-76, no. 1, pp. 81–97, 2005. View at Publisher · View at Google Scholar · View at PubMed
  95. A. Cimmino, G. A. Calin, M. Fabbri, et al., “miR-15 and miR-16 induce apoptosis by targeting BCL2,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 39, pp. 13944–13949, 2005. View at Publisher · View at Google Scholar · View at PubMed
  96. S. A. Ciafrè, S. Galardi, A. Mangiola, et al., “Extensive modulation of a set of microRNAs in primary glioblastoma,” Biochemical and Biophysical Research Communications, vol. 334, no. 4, pp. 1351–1358, 2005. View at Publisher · View at Google Scholar · View at PubMed
  97. T. Papagiannakopoulos and K. S. Kosik, “microRNAs: regulators of oncogenesis and stemness,” BMC Medicine, vol. 6, article 15, 2008. View at Publisher · View at Google Scholar · View at PubMed
  98. S. Lawler and E. A. Chiocca, “Emerging functions of microRNAs in glioblastoma,” Journal of Neuro-Oncology, vol. 92, no. 3, pp. 297–306, 2009. View at Publisher · View at Google Scholar · View at PubMed
  99. E. Ferretti, E. De Smaele, A. Po, et al., “microRNA profiling in human medulloblastoma,” International Journal of Cancer, vol. 124, no. 3, pp. 568–577, 2009. View at Publisher · View at Google Scholar · View at PubMed
  100. N. Bushati and S. M. Cohen, “microRNAs in neurodegeneration,” Current Opinion in Neurobiology, vol. 18, no. 3, pp. 292–296, 2008. View at Publisher · View at Google Scholar · View at PubMed
  101. C. Patterson, J. W. Feightner, A. Garcia, G.-Y. R. Hsiung, C. MacKnight, and A. D. Sadovnick, “Diagnosis and treatment of dementia: 1. Risk assessment and primary prevention of Alzheimer disease,” Canadian Medical Association Journal, vol. 178, no. 5, pp. 548–556, 2008. View at Publisher · View at Google Scholar · View at PubMed
  102. A. Orlacchio, G. Bernardi, A. Orlacchio, and S. Martino, “RNA interference as a tool for Alzheimer's disease therapy,” Mini-Reviews in Medicinal Chemistry, vol. 7, no. 11, pp. 1166–1176, 2007. View at Publisher · View at Google Scholar
  103. E. Costanzi, S. Martino, E. Persichetti, et al., “Effects of vitamin C on fibroblasts from sporadic Alzheimer's disease patients,” Neurochemical Research, vol. 33, no. 12, pp. 2510–2515, 2008. View at Publisher · View at Google Scholar · View at PubMed
  104. E. A. Rogaeva, S. Premkumar, J. Grubber, et al., “An α-2-macroglobulin insertion-deletion polymorphism in Alzheimer disease,” Nature Genetics, vol. 22, no. 1, pp. 19–22, 1999. View at Publisher · View at Google Scholar · View at PubMed
  105. J. W. Freeman, M. Simmons, and E. Matos, “Parkinson disease: an incremental challenge,” South Dakota Medicine, vol. 60, no. 12, pp. 481–484, 2007.
  106. C. Balducci, L. Pierguidi, E. Persichetti, et al., “Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease,” Movement Disorders, vol. 22, no. 10, pp. 1481–1484, 2007. View at Publisher · View at Google Scholar · View at PubMed
  107. W. Stamey and J. Jankovic, “Impulse control disorders and pathological gambling in patients with parkinson disease,” Neurologist, vol. 14, no. 2, pp. 89–99, 2008. View at Publisher · View at Google Scholar · View at PubMed
  108. G. G. Kovacs and H. Budka, “Prion diseases: from protein to cell pathology,” American Journal of Pathology, vol. 172, no. 3, pp. 555–565, 2008. View at Publisher · View at Google Scholar · View at PubMed
  109. V. B. Tripathi and A. Al-Chalabi, “Molecular insights and therapeutic targets in amyotrophic lateral sclerosis,” CNS and Neurological Disorders—Drug Targets, vol. 7, no. 1, pp. 11–19, 2008. View at Publisher · View at Google Scholar
  110. A. Orlacchio, G. Bernardi, A. Orlacchio, and S. Martino, “Genetics of amyotrophic lateral sclerosis,” Recent Research in Developmental Neuroscience, pp. 17–54, 2007.
  111. A. Orlacchio, T. Kawarai, A. Totaro, et al., “Hereditary spastic paraplegia: clinical genetic study of 15 families,” Archives of Neurology, vol. 61, no. 6, pp. 849–855, 2004. View at Publisher · View at Google Scholar · View at PubMed
  112. A. Orlacchio, T. Kawarai, F. Gaudiello, P. H. St. George-Hyslop, R. Floris, and G. Bernardi, “New locus for hereditary spastic paraplegia maps to chromosome 1p31.1–1p21.1,” Annals of Neurology, vol. 58, no. 3, pp. 423–429, 2005. View at Publisher · View at Google Scholar · View at PubMed
  113. E. C. Stack and R. J. Ferrante, “Huntington's disease: progress and potential in the field,” Expert Opinion on Investigational Drugs, vol. 16, no. 12, pp. 1933–1953, 2007. View at Publisher · View at Google Scholar · View at PubMed
  114. E. J. Wild and S. J. Tabrizi, “Huntington's disease phenocopy syndromes,” Current Opinion in Neurology, vol. 20, no. 6, pp. 681–687, 2007. View at Publisher · View at Google Scholar · View at PubMed
  115. S. Martino, C. Emiliani, B. Tancini, et al., “Absence of metabolic cross-correction in Tay-Sachs cells: implications for gene therapy,” Journal of Biological Chemistry, vol. 277, no. 23, pp. 20177–20184, 2002. View at Publisher · View at Google Scholar · View at PubMed
  116. S. Martino, C. Cavalieri, C. Emiliani, et al., “Restoration of the GM2 ganglioside metabolism in bone marrow-derived stromal cells from Tay-Sachs disease animal model,” Neurochemical Research, vol. 27, no. 7-8, pp. 793–800, 2002. View at Publisher · View at Google Scholar
  117. S. Martino, P. Marconi, B. Tancini, et al., “A direct gene transfer strategy via brain internal capsule reverses the biochemical defect in Tay-Sachs disease,” Human Molecular Genetics, vol. 14, no. 15, pp. 2113–2123, 2005. View at Publisher · View at Google Scholar · View at PubMed
  118. S. Martino and A. Orlacchio, “Cellule staminali e GM2 gangliosidosi,” Annali dell'Istituto Superiore di Sanità, pp. 27–28, 2005.
  119. S. Martino, I. di Girolamo, C. Cavazzin, et al., “Neural precursor cell cultures from GM2 gangliosidosis animal models recapitulate the biochemical and molecular hallmarks of the brain pathology,” Journal of Neurochemistry, vol. 109, no. 1, pp. 135–147, 2009. View at Publisher · View at Google Scholar · View at PubMed
  120. M. S. Weinberg and M. J. A. Wood, “Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics,” Human Molecular Genetics, vol. 18, no. R1, pp. R27–R39, 2009. View at Publisher · View at Google Scholar · View at PubMed
  121. M. Goedert and M. G. Spillantini, “A century of Alzheimer's disease,” Science, vol. 314, no. 5800, pp. 777–781, 2006. View at Publisher · View at Google Scholar · View at PubMed
  122. P. T. Lansbury and H. A. Lashuel, “A century-old debate on protein aggregation and neurodegeneration enters the clinic,” Nature, vol. 443, no. 7113, pp. 774–779, 2006. View at Publisher · View at Google Scholar · View at PubMed
  123. R. S. Turner, “Alzheimer's disease,” Seminars in Neurology, vol. 26, no. 5, pp. 499–506, 2006. View at Publisher · View at Google Scholar · View at PubMed
  124. Y. Ohyagi and T. Tabira, “Intracellular amyloid β-protein and its associated molecules in the pathogenesis of Alzheimer's disease,” Mini-Reviews in Medicinal Chemistry, vol. 6, no. 10, pp. 1075–1080, 2006. View at Publisher · View at Google Scholar
  125. D. Goldgaber, M. I. Lerman, and O. W. McBride, “Characterization and chromosomal localization of a cDNA encodingbrain amyloid of Alzheimer's disease,” Science, vol. 235, no. 4791, pp. 877–880, 1987.
  126. C. E. Hunt and A. J. Turner, “Cell biology, regulation and inhibition of β-secretase (BACE-1),” FEBS Journal, vol. 276, no. 7, pp. 1845–1859, 2009. View at Publisher · View at Google Scholar · View at PubMed
  127. W.-X. Wang, B. W. Rajeev, A. J. Stromberg, et al., “The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of β-site amyloid precursor protein-cleaving enzyme 1,” Journal of Neuroscience, vol. 28, no. 5, pp. 1213–1223, 2008. View at Publisher · View at Google Scholar · View at PubMed
  128. S. Bicker and G. Schratt, “microRNAs: tiny regulators of synapse function in development and disease,” Journal of Cellular and Molecular Medicine, vol. 12, no. 5A, pp. 1466–1476, 2008. View at Publisher · View at Google Scholar · View at PubMed
  129. D. C. Carrettiero, I. Hernandez, P. Neveu, T. Papagiannakopoulos, and K. S. Kosik, “The cochaperone BAG2 sweeps paired helical filament-insoluble tau from the microtubule,” Journal of Neuroscience, vol. 29, no. 7, pp. 2151–2161, 2009. View at Publisher · View at Google Scholar · View at PubMed
  130. M. M. Hoehn and M. D. Yahr, “Parkinsonism: onset, progression, and mortality,” Neurology, vol. 57, no. 10, pp. S11–S26, 2001.
  131. R. L. Nussbaum and M. H. Polymeropoulos, “Genetics of Parkinson's disease,” Human Molecular Genetics, vol. 6, no. 10, pp. 1687–1691, 1997. View at Publisher · View at Google Scholar
  132. M. H. Polymeropoulos, C. Lavedan, E. Leroy, et al., “Mutation in the α-synuclein gene identified in families with Parkinson's disease,” Science, vol. 276, no. 5321, pp. 2045–2047, 1997. View at Publisher · View at Google Scholar
  133. V. M. Miller, H. Xia, G. L. Marrs, et al., “Allele-specific silencing of dominant disease genes,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 12, pp. 7195–7200, 2003. View at Publisher · View at Google Scholar · View at PubMed
  134. P. Gonzalez-Alegre, V. M. Miller, B. L. Davidson, and H. L. Paulson, “Toward therapy for DYT1 dystonia: allele-specific silencing of mutant Torsin A,” Annals of Neurology, vol. 53, no. 6, pp. 781–787, 2003. View at Publisher · View at Google Scholar · View at PubMed
  135. P. van den Munckhof, K. C. Luk, L. Ste-Marie, et al., “Pitx3 is required for motor activity and for survival of a subset of midbrain dopaminergic neurons,” Development, vol. 130, no. 11, pp. 2535–2542, 2003. View at Publisher · View at Google Scholar
  136. J. Fuchs, J. C. Mueller, P. Lichtner, et al., “The transcription factor PITX3 is associated with sporadic Parkinson's disease,” Neurobiology of Aging, vol. 30, no. 5, pp. 731–738, 2009. View at Publisher · View at Google Scholar · View at PubMed
  137. T. L. Cuellar, T. H. Davis, P. T. Nelson, et al., “Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 14, pp. 5614–5619, 2008. View at Publisher · View at Google Scholar · View at PubMed
  138. A. H. Evans and A. J. Lees, “Dopamine dysregulation syndrome in Parkinson's disease,” Current Opinion in Neurology, vol. 17, no. 4, pp. 393–398, 2004. View at Publisher · View at Google Scholar
  139. G. Wang, J. M. van der Walt, G. Mayhew, et al., “Variation in the miRNA-433 binding site of FGF20 confers Risk for Parkinson disease by overexpression of α-synuclein,” American Journal of Human Genetics, vol. 82, no. 2, pp. 283–289, 2008. View at Publisher · View at Google Scholar · View at PubMed
  140. H. T. Orr and H. Y. Zoghbi, “Trinucleotide repeat disorders,” Annual Review of Neuroscience, vol. 30, pp. 575–621, 2007. View at Publisher · View at Google Scholar · View at PubMed
  141. A. Schaefer, D. O'Carroll, L. T. Chan, et al., “Cerebellar neurodegeneration in the absence of microRNAs,” Journal of Experimental Medicine, vol. 204, no. 7, pp. 1553–1558, 2007. View at Publisher · View at Google Scholar · View at PubMed
  142. J. Bilen, N. Liu, and N. M. Bonini, “A new role for microRNA pathways: modulation of degeneration induced by pathogenic human disease proteins,” Cell Cycle, vol. 5, no. 24, pp. 2835–2838, 2006.
  143. K. Nakamura and M. J. Aminoff, “Huntington's disease: clinical characteristics, pathogenesis and therapies,” Drugs of Today, vol. 43, no. 2, pp. 97–116, 2007. View at Publisher · View at Google Scholar · View at PubMed
  144. S. Q. Harper, P. D. Staber, X. He, et al., “RNA interference improves motor and neuropathological abnormalities in a Huntington's disease mouse model,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 16, pp. 5820–5825, 2005. View at Publisher · View at Google Scholar · View at PubMed
  145. E. Rodriguez-Lebron, E. M. Denovan-Wright, K. Nash, A. S. Lewin, and R. J. Mandel, “Intrastriatal rAAV-mediated delivery of anti-huntingtin shRNAs induces partial reversal of disease progression in R6/1 Huntington's disease transgenic mice,” Molecular Therapy, vol. 12, no. 4, pp. 618–633, 2005. View at Publisher · View at Google Scholar · View at PubMed
  146. J. L. McBride, R. L. Boudreau, S. Q. Harper, et al., “Artificial miRNAs mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi,” Proceedings of the National Academy of Sciences of the United States of America, vol. 105, no. 15, pp. 5868–5873, 2008. View at Publisher · View at Google Scholar · View at PubMed
  147. Y. Li, L. Lin, and P. Jin, “The microRNA pathway and fragile X mental retardation protein,” Biochimica et Biophysica Acta, vol. 1779, no. 11, pp. 702–705, 2008. View at Publisher · View at Google Scholar · View at PubMed
  148. S. T. Warren and S. L. Sherman, “The fragile X syndrome,” in The Metabolic and Molecular Bases of Inherited Disease, vol. 1, pp. 1257–1290, McGraw-Hill, New York, NY, USA, 2001.
  149. S. T. Warren and D. L. Nelson, “Advances in molecular analysis of fragile X syndrome,” Journal of the American Medical Association, vol. 271, no. 7, pp. 536–542, 1994. View at Publisher · View at Google Scholar
  150. G. J. Bassell and S. T. Warren, “Fragile X syndrome: loss of local mRNA regulation alters synaptic development and function,” Neuron, vol. 60, no. 2, pp. 201–214, 2008. View at Publisher · View at Google Scholar · View at PubMed
  151. A. A. Caudy, M. Myers, G. J. Hannon, and S. M. Hammond, “Fragile X-related protein and VIG associate with the RNA interference machinery,” Genes and Development, vol. 16, no. 19, pp. 2491–2496, 2002. View at Publisher · View at Google Scholar · View at PubMed
  152. A. Ishizuka, M. C. Siomi, and H. Siomi, “A Drosophila fragile X protein interacts with components of RNAi and ribosomal proteins,” Genes and Development, vol. 16, no. 19, pp. 2497–2508, 2002. View at Publisher · View at Google Scholar · View at PubMed
  153. P. Jin, D. C. Zarnescu, S. Ceman, et al., “Biochemical and genetic interaction between the fragile X mental retardation protein 3nd the microRNA pathway,” Nature Neuroscience, vol. 7, no. 2, pp. 113–117, 2004. View at Publisher · View at Google Scholar · View at PubMed
  154. I. Plante, L. Davidovic, D. L. Ouellet, et al., “Dicer-derived microRNAs are utilized by the fragile X mental retardation protein for assembly on target RNAs,” Journal of Biomedicine and Biotechnology, vol. 2006, Article ID 64347, 12 pages, 2006. View at Publisher · View at Google Scholar · View at PubMed
  155. P. Jin, R. S. Alisch, and S. T. Warren, “RNA and microRNAs in fragile X mental retardation,” Nature Cell Biology, vol. 6, no. 11, pp. 1048–1053, 2004. View at Publisher · View at Google Scholar · View at PubMed
  156. M. P. Perron and P. Provost, “Protein components of the microRNA pathway and human diseases,” Methods in Molecular Biology, vol. 487, pp. 369–385, 2009.
  157. A. Cheever and S. Ceman, “Translation regulation of mRNAs by the fragile X family of proteins through the microRNA pathway,” RNA Biology, vol. 6, no. 2, pp. 175–178, 2009.
  158. M. Costa-Mattioli, W. S. Sossin, E. Klann, and N. Sonenberg, “Translational control of long-lasting synaptic plasticity and memory,” Neuron, vol. 61, no. 1, pp. 10–26, 2009. View at Publisher · View at Google Scholar · View at PubMed
  159. R. Duan and P. Jin, “Identification of messenger RNAs and microRNAs associated with fragile X mental retardation protein,” Methods in Molecular Biology, vol. 342, pp. 267–276, 2006.
  160. A. Cheever and S. Ceman, “Phosphorylation of FMRP inhibits association with Dicer,” RNA, vol. 15, no. 3, pp. 362–366, 2009. View at Publisher · View at Google Scholar · View at PubMed
  161. X.-L. Xu, Y. Li, F. Wang, and F.-B. Gao, “The steady-state level of the nervous-system-specific microRNA-124a is regulated by dFMR1 in Drosophila,” Journal of Neuroscience, vol. 28, no. 46, pp. 11883–11889, 2008. View at Publisher · View at Google Scholar · View at PubMed
  162. Y. Yang, S. Xu, L. Xia, et al., “The bantam microRNA is associated with Drosophila fragile X mental retardation protein and regulates the fate of germline stem cells,” PLoS Genetics, vol. 5, no. 4, article e1000444, 2009. View at Publisher · View at Google Scholar · View at PubMed
  163. T. Nomura, M. Kimura, T. Horii, et al., “MeCP2-dependent repression of an imprinted miR-184 released by depolarization,” Human Molecular Genetics, vol. 17, no. 8, pp. 1192–1199, 2008. View at Publisher · View at Google Scholar · View at PubMed
  164. N. R. Smalheiser and G. Lugli, “microRNA Regulation of Synaptic Plasticity,” NeuroMolecular Medicine, vol. 11, no. 3, pp. 133–140, 2009. View at Publisher · View at Google Scholar · View at PubMed
  165. J. F. Abelson, K. Y. Kwan, B. J. O'Roak, et al., “Sequence variants in SLITRK1 are associated with Tourette's syndrome,” Science, vol. 310, no. 5746, pp. 317–320, 2005. View at Publisher · View at Google Scholar · View at PubMed
  166. L. Zhang, J. Huang, N. Yang, et al., “microRNAs exhibit high frequency genomic alterations in human cancer,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 24, pp. 9136–9141, 2006. View at Publisher · View at Google Scholar · View at PubMed
  167. A. Esquela-Kerscher and F. J. Slack, “Oncomirs—microRNAs with a role in cancer,” Nature Reviews Cancer, vol. 6, no. 4, pp. 259–269, 2006. View at Publisher · View at Google Scholar · View at PubMed
  168. T. Papagiannakopoulos, A. Shapiro, and K. S. Kosik, “microRNA-21 targets a network of key tumor-suppressive pathways in glioblastoma cells,” Cancer Research, vol. 68, no. 19, pp. 8164–8172, 2008. View at Publisher · View at Google Scholar · View at PubMed
  169. M. S. Nicoloso and G. A. Calin, “microRNA involvement in brain tumors: from bench to bedside,” Brain Pathology, vol. 18, no. 1, pp. 122–129, 2008. View at Publisher · View at Google Scholar · View at PubMed
  170. G. A. Calin, C. Sevignani, C. D. Dumitru, et al., “Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers,” Proceedings of the National Academy of Sciences of the United States of America, vol. 101, no. 9, pp. 2999–3004, 2004. View at Publisher · View at Google Scholar · View at PubMed
  171. S. Volinia, G. A. Calin, C.-G. Liu, et al., “A microRNA expression signature of human solid tumors defines cancer gene targets,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 7, pp. 2257–2261, 2006. View at Publisher · View at Google Scholar · View at PubMed
  172. L. He, J. M. Thomson, M. T. Hemann, et al., “A microRNA polycistron as a potential human oncogene,” Nature, vol. 435, no. 7043, pp. 828–833, 2005. View at Publisher · View at Google Scholar · View at PubMed
  173. G. A. Calin and C. M. Croce, “microRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at PubMed
  174. C. R. Woese, The Genetic Code, Harper and Row, New York, NY, USA, 1968.
  175. T. A. Lincoln and G. F. Joyce, “Self-sustained replication of an RNA enzyme,” Science, vol. 323, no. 5918, pp. 1229–1232, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  176. P. A. Sharp, “The Centrality of RNA,” Cell, vol. 136, no. 4, pp. 577–580, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  177. T. R. Cech, “Crawling out of the RNA world,” Cell, vol. 136, no. 4, pp. 599–602, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  178. C. D. Malone and G. J. Hannon, “Small RNAs as guardians of the genome,” Cell, vol. 136, no. 4, pp. 656–668, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  179. W. Kong, J.-J. Zhao, L. He, and J. Q. Cheng, “Strategies for profiling microRNA expression,” Journal of Cellular Physiology, vol. 218, no. 1, pp. 22–25, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  180. L. Bonetta, “RNA-based therapeutics: ready for delivery?” Cell, vol. 136, no. 4, pp. 581–584, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  181. T. Thum, C. Gross, J. Fiedler, et al., “microRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts,” Nature, vol. 456, no. 7224, pp. 980–984, 2008. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  182. T. Würdinger and B. A. Tannous, “Glioma angiogenesis: towards novel RNA therapeutics,” Cell Adhesion and Migration, vol. 3, no. 2, pp. 230–235, 2009. View at Scopus